Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.1344 | 0.3002 | 1 |
Echinococcus granulosus | geminin | 0.0205 | 0.0315 | 0.1049 |
Echinococcus granulosus | Squalene phytoene synthase | 0.1344 | 0.3002 | 1 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.0506 | 0.1685 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.0315 | 0.1049 |
Echinococcus multilocularis | Squalene phytoene synthase | 0.1344 | 0.3002 | 1 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.0506 | 0.1685 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.0506 | 0.1685 |
Trypanosoma cruzi | squalene synthase, putative | 0.4313 | 1 | 1 |
Mycobacterium ulcerans | phytoene synthase, CrtB | 0.1344 | 0.3002 | 0.5 |
Trypanosoma cruzi | squalene synthase, putative | 0.4313 | 1 | 1 |
Trypanosoma brucei | squalene synthase, putative | 0.4313 | 1 | 0.5 |
Mycobacterium tuberculosis | Probable phytoene synthase PhyA | 0.1344 | 0.3002 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.0315 | 0.1049 |
Onchocerca volvulus | NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 homolog | 0.1344 | 0.3002 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.1344 | 0.3002 | 1 |
Echinococcus multilocularis | geminin | 0.0205 | 0.0315 | 0.1049 |
Brugia malayi | hypothetical protein | 0.0286 | 0.0506 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 6.5131 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.